YungShin Global Holding Corp Total Liabilities
YungShin Global Holding Corp total liabilities. Based on the latest financial reports, YungShin Global Holding Corp (3705) has total liabilities worth NT$4.59 Billion TWD (≈ $144.68 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check YungShin Global Holding Corp (3705) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of YungShin Global Holding Corp (2000–2025)
Total liabilities of YungShin Global Holding Corp from 2000 to 2025. This chart illustrates how YungShin Global Holding Corp's total liabilities have evolved over time, based on quarterly financial data. Explore how much of YungShin Global Holding Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.
YungShin Global Holding Corp Competitors by Total Liabilities
The table below lists competitors of YungShin Global Holding Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sikarin Public Company Limited
BK:SKR
|
Thailand | ฿1.65 Billion |
|
Huasu Holdings Co Ltd
SHE:000509
|
China | CN¥666.23 Million |
|
YG Entertainment Inc
KQ:122870
|
Korea | ₩209.26 Billion |
|
BIOCYTOGEN PHARMA. H YC1
F:I54
|
Germany | €1.54 Billion |
|
Sierra Bancorp
NASDAQ:BSRR
|
USA | $3.40 Billion |
|
Gansu Yatai Industrial Development Co Ltd
SHE:000691
|
China | CN¥548.96 Million |
|
Beijing ConST Instruments Technology Inc
SHE:300445
|
China | CN¥118.87 Million |
|
Egetis Therapeutics AB (publ)
ST:EGTX
|
Sweden | Skr288.70 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down YungShin Global Holding Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 3705 current and non-current assets.
Liquidity & Leverage Metrics
YungShin Global Holding Corp Total Liabilities Ratios Explained
YungShin Global Holding Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how YungShin Global Holding Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for YungShin Global Holding Corp (2000–2025)
The table below shows the annual total liabilities of YungShin Global Holding Corp from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$3.64 Billion ≈ $114.61 Million |
-4.81% |
| 2024-12-31 | NT$3.82 Billion ≈ $120.41 Million |
+6.23% |
| 2023-12-31 | NT$3.60 Billion ≈ $113.34 Million |
-13.30% |
| 2022-12-31 | NT$4.15 Billion ≈ $130.73 Million |
-20.52% |
| 2021-12-31 | NT$5.22 Billion ≈ $164.50 Million |
-13.49% |
| 2020-12-31 | NT$6.04 Billion ≈ $190.16 Million |
+1.60% |
| 2019-12-31 | NT$5.94 Billion ≈ $187.16 Million |
+6.73% |
| 2018-12-31 | NT$5.57 Billion ≈ $175.37 Million |
+11.42% |
| 2017-12-31 | NT$5.00 Billion ≈ $157.39 Million |
+19.67% |
| 2016-12-31 | NT$4.17 Billion ≈ $131.51 Million |
+34.42% |
| 2015-12-31 | NT$3.11 Billion ≈ $97.84 Million |
+11.07% |
| 2014-12-31 | NT$2.80 Billion ≈ $88.08 Million |
+8.12% |
| 2013-12-31 | NT$2.59 Billion ≈ $81.47 Million |
+43.96% |
| 2012-12-31 | NT$1.80 Billion ≈ $56.59 Million |
+12.40% |
| 2011-12-31 | NT$1.60 Billion ≈ $50.35 Million |
+19.81% |
| 2010-12-31 | NT$1.33 Billion ≈ $42.03 Million |
+5.66% |
| 2009-12-31 | NT$1.26 Billion ≈ $39.77 Million |
+14.03% |
| 2008-12-31 | NT$1.11 Billion ≈ $34.88 Million |
-20.56% |
| 2007-12-31 | NT$1.39 Billion ≈ $43.91 Million |
+81.46% |
| 2006-12-31 | NT$768.03 Million ≈ $24.20 Million |
-5.74% |
| 2005-12-31 | NT$814.77 Million ≈ $25.67 Million |
-57.65% |
| 2004-12-31 | NT$1.92 Billion ≈ $60.61 Million |
+10.17% |
| 2003-12-31 | NT$1.75 Billion ≈ $55.02 Million |
+2.26% |
| 2002-12-31 | NT$1.71 Billion ≈ $53.80 Million |
+12.02% |
| 2001-12-31 | NT$1.52 Billion ≈ $48.03 Million |
+76.37% |
| 2000-12-31 | NT$864.33 Million ≈ $27.23 Million |
-- |
About YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, M… Read more